Silence Therapeutics

SILENCE THERAPEUTICS PLC-ADR

Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA. Using its mRNAi GOLD platform, the company has generated siRNA product candidates both for internal development pipeline as well as for out-licensed programs with third-party collaborators. Its wholly owned pipeline is focused on three therapeutic areas: cardiovascular disease, hematology, and rare diseases. The different product candidates in its pipeline are Divesiran (SLN124), a siRNA product candidate that has the potential to treat several hematological disorders; Zerlasiran (SLN360), being developed as a potential treatment to reduce cardiovascular issues; SLN-312; SLN-548; and multiple other programs.

IBM stock

News

Initiation

Pre-Market Outlook

Markets

Analyst Ratings

Trading Ideas

GAIA

STLD

This IBM Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

Bernie's Concerns With Healthcare Costs

Long Ideas

MODV

OLMA

Top 3 Health Care Stocks That May Explode In Q4

Soleno Therapeutics (SLNO)

Analyst Color

Biotech

Health Care

Price Target

Movers

General

AMGN

Silence Therapeutics&#39; Phase 2 data shows zerlasiran achieves over 80% Lp(a) reduction in ASCVD patients but faces dosing frequency challenges.

Silence Therapeutics&#39; Zerlasiran Has Competitive Concerns: Analyst

Silence Therapeutics Plc - American Depository Share

Silence Therapeutics PLC

SELINA HOSPITALITY PLC HS

SELINA HOSPITALITY PLC by Selina Hospitality PLC

Selina Hospitality PLC

SILENCE THERAPEUTICS ORD by Silence Therapeutics, Plc.

Southland Holdings Inc

SOLUTION FINL INC by Solution Financial Inc.

Solution Financial Inc

Stabilis Solutions Inc

Soluna Holdings Inc

Soluna Holdings, Inc. - 9.0% Series A Cumulative Perpetual Preferred Stock

STELLA INTL HLDGS LTD ORD by Stella International Holdings Ltd.

Stella International Holdings Ltd

STELLA INTL HLDG UNSP/ADR by Stella International Holdings Ltd.

SALON MEDIA GROUP INC by Salon Media Group, Inc.

Salon Media Group Inc

Soleno Therapeutics Inc

SOLUTIONS 30 SE UNSP/ADR by Solutions 30 S.E.

Solutions 30 SE

Selina Hospitality PLC Warrants (27/10/2027)

SOLANBRIDGE GROUP INC by Solanbridge Group, Inc.

Solanbridge Group Inc

TCW Senior Loan ETF

Press Releases

Silence Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights

Silence Therapeutics Presents Late-Breaking Phase 2 Zerlasiran Data at 2024 American Heart Association (AHA) Annual Meeting

Silence Therapeutics to Participate in Fireside Chat at Piper Sandler 36th Annual Healthcare Conference

Silence Therapeutics Presents Promising Phase 1 Data in Polycythemia Vera Patients at the American Society of Hematology (ASH) Annual Meeting

Silence Therapeutics to Report Fourth Quarter and Full Year 2024 Results on February 27, 2025

Silence Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update

Silence Therapeutics to Webcast Presentation at the Leerink Partners Global Healthcare Conference

Silence Therapeutics Welcomes Tim McInerney to Board of Directors

Silence Therapeutics Reports First Quarter 2025 Financial Results and Recent Business Highlights

Silence Therapeutics Presents Additional Phase 1 Data Highlighting Promise of Divesiran as the Potential First-in-Class siRNA Treatment for Polycythemia Vera

Annexon

Candel Therapeutics

Perspective Therapeutics, Inc. Common Stock

Perspective Therapeutics

Crescent Biopharma

Cardiff Oncology

DBV Technologies S.A. - American Depositary Shares

DBV Technologies

Design Therapeutics

Fennec Pharmaceuticals Inc. - Common Stock

Fennec Pharmaceuticals

Foghorn Therapeutics

Immutep Limited - American Depositary Shares

Immutep

Inhibrx Biosciences

Inozyme Pharma

Lexicon Pharmaceuticals, Inc. - Common Stock

Lexicon Pharmaceuticals

Monopar Therapeutics

Nanobiotix

Neurogene

Prime Medicine

Palvella Therapeutics, Inc. - Common Stock

Palvella Therapeutics

Cartesian Therapeutics, Inc. - Common Stock

Cartesian Therapeutics

Sagimet Biosciences Inc. - Series A Common Stock

Sagimet Biosciences

Tonix Pharmaceuticals Holding Corp. - Common Stock

Tonix Pharmaceuticals

Entrada Therapeutics, Inc. - Common Stock

Entrada Therapeutics

Tevogen Bio Holdings

Vanda Pharmaceuticals Inc. - Common Stock

Comments

Silence Therapeutics

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell